March 6, 2024 · Form 4 insider transaction
Lantheus Alpha Therapy, LLC bought 60,431,039 shares of Perspective Therapeutics, Inc. at $0.95 per share, a transaction worth $57.41M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership.